Skip to main content

Continuous Distribution of Hearts Update, Summer 2024

eye iconAt a glance

Background

In December 2018, the OPTN Board of Directors approved the continuous distribution framework for allocation of all organs. Continuous distribution will rank waiting list candidates based on points for various factors, such as medical urgency, candidate biology, patient access, and placement efficiency. Continuous distribution will remove the hard boundaries built into the current framework to increase equity for patients and transparency in the system.

This update builds upon the OPTN Heart Transplantation Committee’s previous work, shares the results from the values prioritization exercise conducted in winter 2024, requests community feedback on the results of the exercise and the attributes being considered for inclusion, and offers next steps for continuous distribution of hearts. test.

Supporting media

Presentation

View presentation PDF link

Project update

  • Values Prioritization Exercise results
    • 702 individuals completed the exercise
    • The overall weight for each attribute from the exercise:
      • 37.4% medical urgency
      • 23.7% pediatric priority
      • 14.1% prior living donor priority
      • 10.8% biological disadvantage priority (points given to candidates based on blood type or level of sensitization)
      • 6.2% post-transplant survival
      • 4.6% waiting time
      • 3.2% proximity efficiency
  • Committee continues to discuss the feedback received from the community during the winter 2024 public comment cycle

Anticipated impact

  • What it's expected to do
    • Provide a more equitable approach to matching candidates and donors
    • Remove hard boundaries that prevent candidates from being prioritized higher on the match run
    • Establish a system that is flexible enough to work for each organ type
  • What it won't do
    • This request for feedback is not a proposed policy change, but will help the Heart Transplantation Committee develop a future policy proposal

Terms to know

  • Attribute: Criteria used to classify then sort and prioritize candidates. For example, in heart allocation, suggested criteria include medical urgency, candidate biology, patient access, and placement efficiency.
  • Values Prioritization Exercise (VPE): An exercise that asks participants to rate the importance of an attribute when it is compared to another attribute.
  • Composite Allocation Score: Combines points from multiple attributes together. This request for feedback proposes the use of composite allocation scores in a points-based framework.

Click here to search the OPTN glossary


Read the full proposal (PDF)

eye iconComments

OPTN Organ Procurement Organization Committee | 09/25/2024

The OPTN Organ Procurement Organization (OPO) Committee thanks the OPTN Heart Transplantation Committee for their efforts on the Heart Continuous Distribution proposal.

One member was surprised by the low score for proximity points, highlighting the difficulty of travel and finding transportation for organs. They suggested that proximity should carry more weight in the allocation system, especially for hearts and lungs. Another member raised concerns about the unequal access to services and technologies between smaller and larger transplant programs. Advanced perfusion technologies, such as TransMedics devices, are more accessible to larger programs, potentially worsening the disparities in transplant opportunities. Members also noted that many Organ Procurement Organizations (OPOs) are obtaining their own perfusion devices. This adds complexity to the allocation process, affecting willingness to travel longer distances and resulting in additional costs and logistics for OPOs.

Region 5 | 09/25/2024

Online feedback showed agreement with the general priority of attributes as identified by the VPE results. An attendee commented that post-transplant survival should be more heavily weighted, since that is the ultimate purpose of the transplant. Virtual attendees provided mixed responses to the relatively low prioritization of the proximity efficiency attribute. An attendee suggested that the committee provide organ non-use rates associated with cold ischemia time due to long distance.

• A member commented that distance may need to be a little higher due to the associated cost and burden related to increased travel and pointed out that not all centers will have the technology available to implement.

• A member suggested that biologically difficult to match should receive more points.

• An attendee asked the committee to ensure that there is pediatric priority for pediatric candidates. Also commented that the OCS system is limited for pediatric programs as well as cost prohibited for smaller programs.

• A member provided a general comment that is applicable to all organs in continuous distribution. They asked that the committee keep in mind directly and indirectly related increased costs associated with continuous distribution implementations.

Gift of Life Michigan | 09/24/2024

We appreciate the Committee’s work on this challenging topic.

We generally support exploration and refinement of Continuous Distribution (CD) of hearts and acknowledge the complexities the Committee must navigate in their work. We, too, were surprised that proximity was rated somewhat low in the Value Prioritization Exercise because we have seen significant expansion in the use of machine preservation devices for heart recovery. We are also aware, though, that emerging technologies are expensive and possibly not available to all patients because not all transplant centers will use those platforms. We are concerned that variability and availability could impact access for patients in areas without those devices.

We are also concerned that donor case duration now routinely exceeds 50 hours. Whether in a donor hospital or Donor Care Unit (DCU), longer cases require more resources and impact the donor’s family. We encourage the Committee to remain mindful of process efficiency as they weigh the variables in CD.

We urge the Committee to continue to seek information about patient outcomes. To the extent it can be predicted and part of any allocation process, it is important for the integrity of transplantation that increasing transplants is tied to improving patients’ lives.

Abbott Laboratories | 09/24/2024

Attachment

View attachment from Abbott Laboratories

Advanced Cardiac Therapies Improving Outcomes Network (ACTION) | 09/24/2024

Overall, do you agree with the general priority of attributes as identified by the VPE results? Why or why not? 

We generally agree with prioritization of medical urgency status and especially agree with the prioritization of Pediatric patients. With regards to medical urgency, the way this policy is structured and how points are awarded can significantly affect the prioritization of pediatric patients. Though the use of mechanical support devices is increasing in pediatrics, there remains a subset of patient for whom mechanical support may not be technically feasible or physiologically beneficial. This challenge is reflected in the number of exception requests needed for adult congenital heart disease patients to secure appropriate urgency status, highlighting the need for a more equitable system for awarding medical urgency points. Many of these patients are arguably less stable than a patient at home on a durable device. Any allocation system should take these individual patient factors into account. Additionally, not all pediatric patients are able to be supported with dischargeable mechanical support. This factor should be taken into consideration due to the inability of these patients to leave the hospital while awaiting transplantation.

The prior living donor attribute received the third highest weighting priority. This is an equity issue for Pediatric candidates. Pediatric living donation is an ethically challenging area and also exceedingly rare. Official policy from the American Academy of Pediatrics states that except in rare circumstances, children should not serve as living donors. Thus, pediatric candidates will NOT have access to these points in the continuous distribution system. 

Biological disadvantage is rather low on this list, but an important consideration for patients with congenital heart disease both pediatric and adult, who have a high burden of sensitizing events and anti-HLA antibodies. Data consistently show that crossing antibodies and chronic AMR/CAV limit post-transplant survival.

Do you agree with the relatively low prioritization of the proximity efficiency attribute suggested by the VPE results?

ACTION Does not have a specific comment on this question aside from what is outlined in the response to Question 3.

How should the Committee consider the use of new perfusion technologies and their impact on travel distance? 

The use of perfusion technologies is growing amongst pediatric transplant centers, but the decision to implement them often depends on the specific center. Financial considerations for the use of this technology can be a barrier. This can put smaller, rural, or remote pediatric centers at a disadvantage. Additionally, perfusion technologies are just one part of the overall logistics involved in organ preservation, so they shouldn't be seen as a reliable indicator of a center's ability to accept organs from longer distances.

Is there any additional information the OPTN could provide to help you better understand the concepts associated with the continuous distribution framework for organ allocation? (Note:The Committee is very interested in hearing from those with a personal connection to organ donation and transplantation.)

We will continue to advocate for consideration of the unique needs of pediatric patients within the transplant allocation system. The details of determining medical urgency status will be of utmost importance in the design of any continuous distribution allocation system.
--
The Advanced Cardiac Therapies Improving Outcomes Network (ACTION, https://www.actionlearningnetwork.org/) is a collaborative learning network that works together to improve critical outcomes for all pediatric and congenital heart failure patients. Much of the work of ACTION has focused on patients on mechanical circulatory support. Our international learning network approach allows us to make critical improvements faster across a collaborative system of patients, families, clinicians, researchers, and industry. As of June 2023, ACTION includes 66 pediatric hospitals in North America, as well as engagement from hospitals in 6 countries.

Heart Failure Society of America | 09/24/2024

attachment

View attachment from Heart Failure Society of America

Khadijah Breathett | 09/24/2024

Thank you to the committee for your thoughtfulness in determining how to make the allocation algorithm allocation more equitable. Please consider the following as you move forward:
1. Consider providing complete transparency throughout this process so that the public can understand exactly how calculations are made.
2. Closely monitor how changes impact allocation by race, ethnicity, and gender. It should be a priority for changes to promote more equitable allocation of heart transplants across groups. Changes that lead to worsening disparities should be corrected promptly. (doi:10.1001/jama.2024.0065, doi:10.1016/j.ajt.2023.02.008; doi:10.1161/JAHA.120.021067; doi:10.1161/CIRCULATIONAHA.120.052254)

Sincerely,
Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA

Region 3 | 09/24/2024

During the meeting, in-person attendees participated in group discussions. The Heart group had mixed response regarding the VPE (Values Prioritization Exercise) results. There was general concern that patients with implanted VADs (Ventricular Assist Devices) who end up waiting a long time won’t get transplanted, and that this situation is not addressed in the CD (Continuous Distribution) framework. There was also feedback that the Heart Committee should give more consideration to including post-transplant outcomes as an attribute in the first iteration of Heart CD given the available data. The group also commented that the Committee should give more weight to the proximity efficiency attribute than it does the waiting time attribute. They added that giving priority to closer proximity (250 NM), makes sense given increased cold ischemic times, cost of transportation and devices. Virtual attendees also provided feedback on key questions. One attendee commented that medical urgency should continue to be a high priority. They also commented that with new procurement technology, distance should be less of a priority. Another attendee responded that they agreed with the general priority of the attributes as identified by the VPE results. 

NATCO | 09/23/2024

NATCO appreciates the efforts of the OPTN Heart Transplantation Committee for their continued work on continuous distribution of hearts. NATCO membership makes the following comments on the items requested for feedback:

1. Overall, NATCO membership agrees with the general priority of attributes identified by the values prioritization exercise (VPE) results, with the following caveats:

a. Concerns over how medical urgency will be defined/managed

b. Points should be awarded for highly sensitized candidates, re-transplant candidates with coronary artery vasculopathy (CAV), long-term durable LVAD patients, candidates with congenital heart disease (CHD) who cannot benefit from mechanical circulatory support due to size and anatomical constraints, as well as pediatric patients.

c. Including post-transplant survival as an important factor.

2. NATCO membership largely agreed with the relatively low prioritization of the proximity efficiency attribute suggested by the VPE results.

3. NATCO membership feels the Heart Transplantation Committee should consider the impact of perfusion technologies implementation. Though the use of perfusion technology allows to transport organs to farther locations, the cost associated may not be financially nor logistically sustainable. Smaller centers may not be able to afford/implement such technologies which would negatively impact those centers as well as access and equity for patients.

Region 11 | 09/23/2024

An in-person attendee expressed surprise at the high priority given to prior living donors, suggesting it shouldn't exceed 5 points. They also emphasized the need to incorporate long-term outcomes into the formula and supported high points for pediatric candidates. The attendee questioned whether younger adults should be considered separately as well. A virtual attendee agreed that long-term post-transplant outcomes should be given higher priority, especially for donor families, to ensure the gift provides the longest benefit. Another virtual participant supported the idea that various factors, not just distance, should affect placement. Regarding proximity efficiency, one virtual attendee disagreed with its low prioritization, citing difficulties in reaching their center and having to pass on organs due to travel logistics.

OPTN Transplant Coordinators Committee | 09/23/2024

The OPTN Transplant Coordinators Committee thanks the OPTN Heart Transplantation Committee for updating them on their continuous distribution work. They understand the challenges in creating a fair distribution system for organ transplants.

The Committee has concerns about the likely increased use of ex-vivo perfusion devices. Programs in underserved or low-income areas might struggle to access these devices. The Committee emphasizes that patients in underserved areas should have equal access to heart transplants.

The Committee appreciates that the Heart Committee plans to keep priority points for pediatric candidates in the proposed system. As they continue to develop the system, the Committee recommends that the Heart Committee pay close attention to how patients transition from pediatric to adult status. This transition can significantly affect both pediatric and adult transplant waiting lists.

International Society for Heart and Lung Transplantation | 09/23/2024

attachment

View attachment from International Society for Heart and Lung Transplantation

American Society for Histocompatibility and Immunogenetics (ASHI) | 09/20/2024

The American Society for Histocompatibility and Immunogenetics (ASHI) and its National Clinical Affairs Committee (NCAC) appreciate the opportunity to provide feedback on this update. ASHI is generally supportive of the prioritization of the attributes as identified by the VPE results. Although the order of prioritization of these attributes seems appropriate, the weight assigned to sensitization may be cause for concern.

In addition, we advocate for database infrastructure for the collection of Recipient/ Donor HLA high resolution typing to further examine potential histocompatibility contributions to early adverse events and investigate the impact of HLA-class II mismatch (risk for denovo DSA) and late events such as chronic rejection phenotypes (CAV).

Region 10 | 09/20/2024

The discussion centered around the prioritization of attributes in the Value Prioritization Exercise (VPE) for heart transplant allocation, revealing mixed opinions among attendees. Some were surprised by the results, particularly the lower emphasis on post-transplant outcomes, a topic of significant concern within the heart transplant community. It was noted that prior living donors were given a higher weight than post-transplant outcomes and biological factors, which many found unexpected. However, the lower prioritization of proximity efficiency was generally accepted, especially given the availability of machine perfusion technologies, which makes proximity less critical. There were differing opinions on whether the VPE results accurately reflect the priority of attributes. Some participants disagreed, feeling that the questions were unclear and did not allow for a fair comparison, particularly regarding left ventricular assist device (LVAD)-related topics. Others agreed with the results but expressed concerns about the interpretation of urgency for LVAD patients. Some participants were uncertain and felt they needed more information to provide a definitive answer. There was also a suggestion that having the VPE results in a written format would help stakeholders better understand and absorb the information. Concerns were raised about the increased use of intra-aortic balloon pumps (IABP) since allocation has prioritized their use. Additionally, the weighting of specific diagnoses within heart failure, such as congenital disease and the need for re-transplant, as well as the integration of current exceptions and time on LVAD, were highlighted as areas needing further consideration. While the heavy weighting of medical urgency was generally supported, some felt that patients who are biologically difficult to match should receive higher priority, given the limited availability of suitable offers for them. The discussion also touched on the importance of focusing on post-transplant survival as a critical consideration in the allocation process.

OPTN Pediatric Transplantation Committee | 09/20/2024

The Pediatric Transplantation Committee appreciates the opportunity to provide feedback on the Continuous Distribution (CD) of Hearts Update. Though potentially difficult to predict, it is concerning that outcomes are not planned to be included in Heart CD attributes; post-transplant outcomes are critically important to the pediatric transplant community. The Committee is encouraged to hear that candidates grouped in Status 1A will be separated out on a continuous scale. Medical urgency varies widely among Status 1A candidates, therefore, candidates with the greatest medical urgency are not adequately prioritized. 

Association of Organ Procurement Organizations | 09/20/2024

AOPO appreciates the update on the OPTN Heart Transplantation Committee’s progress, and the results of the values prioritization exercise (VPE) conducted earlier this year. AOPO agrees with the general prioritization of the attributes identified in the VPE, as the results of the exercise demonstrated consensus across all stakeholder groups.

Allocation efficiency remains of great importance to AOPO and its members. The proximity of recipient to donor hospitals remains important to minimize transportation challenges, minimize cold ischemic time, and stretch the limited resources of aircraft availability, pilot time, and transplant center procurement staff. In addition, with changes in allocation and broader sharing average case time for donation has increased from 37.32 hours in 2016 to 51.89 hours in 2024 (see graph attached). This increased case time is an additional burden to donor families already grieving the loss of a loved one. They are now being asked to further delay funeral or memorial arrangements for their loved one.

AOPO encourages the Committee to consider donor factors, such as increased case time, which could be used to impact the proximity calculation. A complex donor, in combination with extended transportation time, could affect a family’s willingness to donate their loved one's organs, acceptance rates, outcomes, and utilization.

Furthermore, with the increasing utilization of DCD hearts for transplantation, it will be important for allocation efficiency that those offers only go to centers willing to consider accepting a DCD heart. AOPO recommends the Committee collect and analyze data regarding the impact of new heart perfusion technologies and consider incorporating these technologies into future iterations of the proximity attribute in CD of hearts.

AOPO continues to emphasize the Committee’s importance in expeditiously developing a model that may serve as the basis for including a post-transplant attribute in an upcoming iteration of CD of hearts. While the Committee’s rationale for not including a post-transplant survival attribute in the first version of Heart CD was sound, it is essential to prioritize post-transplant survival in early updates of Heart CD to prevent futile transplants.

View attachment from Association of Organ Procurement Organizations

Region 7 | 09/17/2024

Attendees generally agreed with the priorities identified by the Values Prioritization Exercise (VPE) results. However, some specific points were raised. Medical need was emphasized as the most important attribute. A virtual attendee stated they were surprised at the high value placed on prior living donor status. Another virtual attendee suggested increasing the weight for proximity efficiency, potentially by reducing the weight for access and urgency attributes slightly. A virtual attendee also noted that new technologies allow programs to consider greater distances without compromising donor quality.

During the meeting, attendees participated in group discussions and provided the following feedback:

• Participants agreed with medical urgency being the highest rated attribute.

• Participants also agreed that pediatric candidates should receive high priority.

• Participants questioned why proximity efficiency is rated so low.

• Participants discussed appropriate level of priority for prior living donors and Heart Committee representative will report back to the Committee.

American Society of Transplant Surgeons | 09/16/2024

Attachment

View attachment from American Society of Transplant Surgeons

OPTN Living Donor Committee | 09/13/2024

The OPTN Living Donor Committee thanks the OPTN Heart Transplantation Committee for their efforts on the Update on Continuous Distribution of Hearts paper.

The Committee strongly supports incorporation of prior living donor priority into the composite allocation score for heart continuous distribution as prior living donors should be acknowledged and receive priority if they were to require a transplant after living organ donation. The Committee supports prioritization of all prior living donors. Although this prioritization status would apply to only a very small number of individuals, it would have a high impact within the living donor and transplant communities by acknowledging the altruism of living donors, demonstrating the value of reciprocity, and recognizing the need to support living donors. The Committee appreciates the OPTN Heart Transplantation Committee’s support of living donors as valued members of the transplant community. The Living Donor Committee offers the following points to consider for inclusion of prior living donor priority into continuous distribution:

·      Prior living donors should receive priority if they are listed for transplant

·      All prior living donors should receive priority for any organ needed

·      Prior living donor priority should not have a time restriction

·      Prior living donors should not be valued differently based on organ donated

·      Prior living donor priority should not be optional to individual candidates

American Society of Transplantation | 09/12/2024

The American Society of Transplantation (AST) offers the following comments in response to the committee update, “Continuous Distribution of Hearts Update, Summer 2024":

•The AST remains in support of

-all sub-categories of priority except for post-transplant survival, with the proviso that a second iteration of this policy incorporates post-transplant survival into prioritization. A suggestion for eventually incorporating post-transplant survival is to include this attribute for weighting but assigning all candidates the same score until an accurate predictive model is developed.

-standardized allocation points for highly sensitized candidates, if unacceptable antigens are recorded in Donornet.

-continued pediatric priority, including continuous monitoring pre- and post-implementation to ensure vulnerable populations such as pediatric recipients are not impacted by unintended consequences not evident in the ongoing analyses to develop a heart continuous distribution allocation algorithm. The current proposal removes the additional priority that children receive in existing policy for pediatric donors. The AST recommends that the Committee consider modeling the addition of points for pediatric candidates when the donor is pediatric (or to add points for donor/recipient pairs that fall within the age brackets mentioned in the comment below).

•The AST’s overarching concern is how the new policy will manage medical urgency. Medical urgency continues to be prioritized in every iteration of heart allocation, without specific regard for age or co-morbidities – attributes which drive post-transplant survival. There is a broad range of risks within each status and thus all the patients within a status should not receive the same points or weight. Data should drive this separation of risk because post-transplant survival remains somewhat problematic, given associations with center expertise (access) and socioeconomic circumstances (insurance coverage of important therapies). One way to incorporate age and co-morbidities into pre-transplant priority is to give points for an age differential less than or equal to 15 years between the candidate and donor. If a candidate is 70 years old, they are prioritized to receive donor offers between 55-70. If a candidate is 25 years old, they are prioritized to receive donor offers between 25-40. This age bracketing component is part of the French Allocation System. All candidates are open to all age donors but gain priority points for age bracketed donor pools.

•The heart allocation system implemented by the OPTN in 2018 included more than 40 mandatory variables collected to move to a cardiac allocation score (CAS). How will these data be used in the development of the heart continuous distribution system? While the hope and goal of continuous distribution is that the different components of the CAS can be changed more expediently without requiring a total policy overhaul, and there are new components that are of great interest to the transplant community (biologic disadvantage), medical urgency of both adult and pediatric heart candidates remain at the forefront of concerns in the heart transplant community.

•The AST believes that patients in need of re-transplantation for severe cardiac allograft vasculopathy including restrictive cardiac physiology (as defined using the International Society for Heart and Lung Transplantation standardized nomenclature for CAV3), should have a higher status than current policy provides due to their high mortality risk.

•The AST agrees with and would like to reiterate prior public comments that prior durable left ventricular assist devices (LVAD) should provide priority status similar to having been a prior organ donor. Every patient who accepts an LVAD instead of a heart transplant allows for a heart that can be transplanted in another patient who anatomically cannot accept LVAD therapy. Given that some patients on LVAD do recover heart function enough to be weaned off, this further increases the donor pool for patients who do not recover.

Region 9 | 09/10/2024

A comment was submitted online that the low prioritization of proximity efficiency in the VPE results did not seem appropriate, given the narrow travel and cold ischemic time windows for donor hearts.  Another commenter stated support for the general priority of attributes, as well as the relatively low priority of the proximity efficiency attribute. 

During the meeting, attendees participated in group discussions and provided the following feedback:

  • The group mostly agreed with the prioritization of attributes as identified by the VPE results. 
  • They felt it was appropriate to prioritize medical urgency over post-transplant outcomes, as they are not well known.   
  • The group supported the lower relative priority for proximity efficiency. 
  • Those in the group with a personal connection to donation and transplant requested more information about continuous distribution that can be easily understood by the average person. A patient may not be receptive to details at the time they are listed and waiting for a transplant, but details should be available to them. 

Mythreyi Govindarajan | 09/06/2024

Thank you for the detailed analysis and sharing the outcome of Values Prioritization Exercise. Ranking biology and composition compared to prior donor living can be re-evaluated especially in case of pediatrics where the kid will not have the ability to sign up for prior donor living.

OPTN Transplant Administrators Committee | 09/04/2024

The OPTN Transplant Administrators Committee appreciates the opportunity to comment on the OPTN Heart Committee’s update on Continuous Distribution of Hearts. The Committee offers the following feedback for consideration:

• The Transplant Administrators Committee wants the Heart Committee to keep in mind that the rise of normothermic technologies has significantly increased the costs associated with heart transplants. This trend may reduce the accessibility of transplants for patients at centers that cannot implement such technology due to financial constraints and long-term financial impacts. 

Overall, the Committee is supportive of the developments on Heart Continuous Distribution and advises that equity be considered in the development process.

Region 6 | 09/03/2024

During the meeting, in-person attendees participated in group discussions and commented that they generally agreed with the VPE (Value Prioritization Exercise) priorities, noting that the identification of prior living donor was interesting, as it offers a way to give back to the community that donates. They also commented that candidates with prolonged waiting times, especially those with durable LVADs, could be at a disadvantage if waiting time is given low priority. They added that the committee will need to determine how to prioritize those on long-term LVAD support. There was also feedback on the relatively low prioritization of the proximity efficiency attribute suggested by the VPE results and noted that proximity efficiency involves the cost and equipment needed to procure distant hearts and brings in quality considerations for transplant centers. Another attendee pointed out that lessons learned from lung continuous distribution indicate that logistical and financial constraints will affect transplant centers. They added that small programs, in particular, are vulnerable, which could lead to closures or behavioral changes. Since over 50% of heart transplant centers fall into the low and mid categories, many could be impacted. One attendee questioned why outcomes after transplant was weighted so low. They went on to comment that there should be a standard weighting for futility across all organs.

Virtual attendees also provided feedback on key questions. One attendee commented that the priority of the attributes in the VPE results seem reasonable, but since a majority of the respondents were transplant clinicians, the results may not reflect the values of the patients, families and members of the public. They went on to comment that they supported the low priority that proximity efficiency received in the VPE results if travel costs are not a consideration, and the only goal is maximizing the number of transplants.

Anonymous | 08/31/2024

I agree with the general priority of attributes, but have concerns: It makes sense to encourage living donation as it increases the available pool of organs. However, could a living donor attribute result in a disparate impact for a candidate who is unable to afford time lost on the job, childcare expenses, or other indirect costs associated with being a living organ donor? If so, how can this be mitigated or resolved?

While I am not opposed to the low prioritization of the proximity efficiency attribute, OPTN should be cautious and realistic when it comes to determining acceptable geographic distances so as not to jeopardize the organ's viability.

Regarding consideration of the use of new perfusion technologies and their impact on travel distance, I am concerned smaller programs might not be able to afford these technologies. This could put their patients at a disadvantage.

I support an attribute of post-transplant survival and look forward to updates on the development of appropriate patient metrics.

Once implemented, the policy must be closely monitored so OPTN can consult with the community to make adjustments when concerns are identified that might undermine equity and/or efficiency.

I am a heart recipient who recently learned of the public comment process. I needed to get up to speed quickly on the continuous distribution concept. The OPTN website has a closer look section on continuous distribution. The section has relevant and easy to understand discussion and videos. I suggest adding a link to the continuous distribution closer look section going forward when seeking public comment on any proposal relating to continuous distribution.

Region 1 | 08/29/2024

A comment was submitted supporting the results of the Values Prioritization Exercise (VPE) and the work of the committee. Another online comment requested the committee consider a higher level of priority on proximity efficiency than what came out of the VPE. They also believe that post-transplant survival should factor into heart continuous distribution, as it is an important part of utility. The commented also noted that thoracic NRP may have an impact on survival and allow hearts to be allocated to more distant candidates. 

During the meeting, attendees participated in group discussions and provided the following feedback: 

•Regarding proximity efficiency, traveling further distances and new preservation technology result in higher and higher costs for programs, which can impact access and equity. Some programs are not able to keep up with these costs, which could jeopardize the survival of small programs.  

•The group had several heart patients participating in the discussion, and they appreciated having the patient perspective. 

Gloria Gubbels | 08/27/2024

Would it be possible to identify heart donors by blood type through a computer program? 1. Collection of data to show where high volume of certain blood types is in the territory assigned to harvest hearts. 2. Collect the data from driver license facilities, physician offices etc. 3. When someone is listed1-6 put the person in the category but with people of the same blood type in that category. "Life is precious, continue your good work that you do for people." Gloria Gubbels

Region 8 | 08/27/2024

Online feedback showed agreement with general priority of attributes as identified by the VPE results. However, an attendee said except the case in which a recipient has been waiting a long time since those recipients are more likely to die waiting on a heart organ. There was some agreement with the relatively low prioritization of the proximity efficiency attribute suggested by the VPE results. But one attendee disagreed with the low prioritization of the proximity efficiency attribute suggested by the VPE results. The attendee explained they believed the thoracic organ offers distance is important, with the understanding that as new preservation technologies are available and become standardized, distance should be less of a deciding factor.

· An attendee requested clarification on multivisceral requirements in allocation. Another attendee pointed out that continuous distribution framework requires more transparency in candidate rating, and explained how factors like religious beliefs affecting medical choices are weighted for unbiased evaluation. They said clarification is needed on how to handle special populations, such as Jehovah's Witnesses refusing blood transfusions, and addressing growing concerns about their acceptance rates. They said it would help to share simulation data on the impact on different patient groups, including those requiring bloodless transplantation. The framework should explain the balance of ethical considerations of equity and utility, reflecting OPTN Ethics Committee recommendations. Additionally, information on the system's adaptability to incorporate advancements in bloodless transplantation and address disparities over time is crucial. And developing patient education materials on fair access regardless of religious beliefs would enhance understanding and potentially contribute to increasing overall transplant numbers.

· For pediatric recipients, attendees recommend constructing a mechanism to retain pediatric priority for pediatric donors, at least to some degree. If the outcomes of continuous distributions of hearts mirrors the outcomes for lung (i.e. traveling further distances for organs), they had concerns about limited access to donor organs in pediatric programs. Further, pediatric programs do not have as much access to organ preservation devices which limits their ability to travel further for organs.

· An attendee implored the committees to consider allocation efficiency in developing equitable organ allocation in relation to the impact of donor families. With the implementation of the lung continuous distribution allocation, the allocation process is extended, adding time required to facilitate gifts given by donor family. On average, donor cases are taking 50-60 hours prior to going to the operating room, which is hard on donor families. The clarification of the multi-organ priorities should help. The attendee explained that as we improve the system, we need to consider the needs of the donor families.

 

During the meeting, in-person attendees participated in group discussions and provided feedback on the following questions:

·  Do you agree with the general priority of attributes as identified by the VPE (Value Prioritization Exercise) results?

o  The group agreed with medical urgency and pediatric priority but felt that candidate biology should have more priority than prior living donor. They also felt that being located close to the donor should have more priority than in the exercise.

·  Do you agree with the relatively low prioritization of the proximity efficiency attribute suggested by the VPE results?

o  A lung colleague described their lung continuous distribution experience and recommended prioritizing pediatric donors for pediatric candidates due to better outcomes.

· The Committee is very interested in hearing from those with a personal connection to organ donation and transplantation and would like to know if there is any additional information the OPTN could provide to help you better understand the concepts associated with the continuous distribution of hearts allocation framework?

o  Recipients agreed with VPE but felt that knowing they are active on the list and offers are coming in is more important and want to consider how to keep families aware of what is happening with organ offers. 

Region 4 | 08/19/2024

The heart group discussed the results of the VPE and agreed that medical urgency should be the primary factor in score. One attendee strongly advocated for giving priority to prior living donors noting that over the past 25 years, the number of prior living donors who are listed for transplant is very low but has a high impact on promoting trust in the system and is important for how the transplant community connects with the community at large. It was noted that for patients with high medical urgency, their points would be so substantial that even if a lower-status patient accumulated additional points from other categories, it would be nearly impossible to surpass the medically urgent patient. Another key discussion focused on the impact of continuous distribution on multi-organ candidates, with concerns raised from an OPO perspective about the challenges of matching organs and the potential for non-compliance with policy.  

Virtual attendees also provided feedback on key questions. Several attendees suggested that proximity should have a higher priority due to increased cold ischemic time with travel and rising travel costs, which threaten program survival. One attendee recommended that post-transplant survival be prioritized similarly to the lung model. Another suggested prioritizing medical urgency, including patients with LVADs. There was also a recommendation for the committee to maintain ongoing communication with the community by providing regular updates. 

Region 2 | 08/16/2024

Feedback submitted online highlighted concerns and support for the new organ allocation system, particularly regarding its impact on smaller transplant centers and rural communities. While there is general support for the inclusion of additional factors in the continuous allocation model, one attendee expressed concern that too much emphasis is being placed on prior living donors, suggesting that more weight should be given to biologically difficult-to-match candidates. There was also apprehension about the financial burden the new system might impose, especially on smaller centers. As seen with the lung allocation transition to a Continuous Allocation Score (CAS), there has been an increase in travel distances and upfront costs, which could force smaller centers—particularly those serving rural communities with limited financial means—out of the system. This raises concerns about how the transplant community will support these centers and ensure equal organ distribution for all patients. Overall, there is acknowledgment that helping those on the waitlist should be a priority, as it would ultimately benefit both costs and health outcomes. However, there is a need for careful consideration of the potential inequities the new system could create. 

 During the meeting, attendees participated in group discussions and provided feedback on the following questions: 

  • Do you agree with the general priority of attributes as identified by the VPE (Value Prioritization Exercise) results? 
  • The feedback on the VPE results was generally supportive and in line with expectations. However, concerns were raised about the negative impact of the current attribute list on stable LVAD (Left Ventricular Assist Device) patients, as it fails to consider the duration of mechanical circulatory support. While the new system is seen as more equitable and patient-centric—similar to the lung allocation model—there is worry that not everyone fully understands the implications of their prioritization choices. One significant concern is the low emphasis placed on post-transplant outcomes. The fear is that this could lead to a system where patients with a longer potential survival suffer poorer outcomes due to extended wait times, while others receive transplants but with significantly worse long-term results. Such extreme outcomes could ultimately be unacceptable to all involved. 
  • Do you agree with the relatively low prioritization of the proximity efficiency attribute suggested by the VPE results?  
  • The discussion on Placement Efficiency raised concerns about equitable access to organs, particularly when some programs have the resources to facilitate long-distance travel, potentially disadvantaging others. The inefficiency of organs crisscrossing the country was highlighted as a poor use of resources. There was acknowledgment of the increasing use of organ perfusion systems like TransMedics, which could improve the ability to transport organs over longer distances. However, the true impact on organ procurement and outcomes is still uncertain and may need to be reassessed in the future. 
  • The Committee is very interested in hearing from those with a personal connection to organ donation and transplantation and would like to know if there is any additional information the OPTN could provide to help you better understand the concepts associated with the continuous distribution of hearts allocation framework?  
  • An attendee noted that the videos and graphics on the OPTN website are simple and easy to understand, which is a good thing.  

Luke Preczewski | 08/02/2024

The proposed weighting does far too little to take into account the logistic and financial aspects of allocation. Past changes have led to a system in which far too many unnecessary flights occur. This has dramatically increased logistic challenges and costs for transplant centers. Additionally, organs that could be successfully transplanted with lower transportation and perfusion costs are going on machines to go greater distances at astronomical costs. This trend is not financially or logistically sustainable, and any future changes need to take this seriously. Unfortunately, this proposal does not.

Jake Kleinmahon | 08/01/2024

Thank you for the careful consideration of characteristics that will go into the future continuous distribution system. I do have a concern about the inclusion of being a previous living donor as a factor. Living donors in pediatrics is ethically challenging. As discussed in the paper "Minors as Living Solid-Organ Donors Pediatrics (2008) 122 (2): 454–461." there is a risk that further incentivizing living donation may lead to coercion of a minor to donate or feelings of guilt or decreased self-worth for minors who have chosen not to donate or whose parents have not let them donate in the past. While adults have the ability to make decisions and consent on their own, lumping children into this is a slippery slope. While pediatric patients will be allocated additional points in the proposed new system, many of them will not have the ability to access additional points if consideration of a living donation is in the algorithm. While a fair percentage of respondents to the survey listed prior living donation as a fairly important consideration, many of the respondents do not take care of children so do not have the perspective of how this may be problematic when applied to the pediatric population. Thank you for the hard work put into coming up with this system and the consideration of my concerns.

She Gay | 07/31/2024

I am a heart recipient 2002 and a heart/kidney recipient 2012. Currently my brother has been on the waiting list for a heart for 4 1/2 years for Status 4. He has an LVad and recently was upgraded to Status 2 Inpatient. My concern is for those waiting in our state and the number of hearts going out of state - out of region. When a local candidate is the same status and other qualifications, I would hope hearts would stay in state. Due to quality of organs being better in the 4-6 hour range (unless "heart in box"), I feel this is an important part of the allocation process.

Aurangzeb Baber | 07/31/2024

There should be more discussion in regards to medical urgency. The current system takes into account medical urgency but still has drawbacks especially when it comes to multi organ failure and need for multi organ transplant. One specific example is patients in need for heart liver or heart lung transplant. In reality they are much sicker but objective data like hemodynamics might not give the full picture.